Defluoro atorvastatin calcium

CAS : 433289-83-9

Ref. 3D-ID156826

Informations sur le produit

• Nom: Defluoro atorvastatin calcium
• Synonymes: Atorvastatin impurity AAtorvastatin related compound A(βR, δR)-β,δ-Dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(pheny lamino)carbo nyl]-1H-pyrrole-1-heptanoic acid calcium (2:1)

Description

Defluoro atorvastatin calcium is a bulk drug that has been approved to be used as an adjunct to diet to reduce elevated cholesterol levels in adults. Defluoro atorvastatin calcium is the desfluoro-enantiomer of atorvastatin, which is a statin that inhibits the enzyme HMG-CoA reductase. This enzyme catalyzes the conversion of HMG-CoA to mevalonic acid, which is an early step in the synthesis of cholesterol. The fluoro group on defluoro atorvastatin calcium is not expected to have any significant effect on its potency or metabolic pathways and any impurities are not expected to have any therapeutic effect.

3-Desacetylcefotaxime potassium (3DCTKP) is an antibacterial agent that belongs to the group of β-lactam antibiotics. It is a prodrug that is hydrolyzed in vivo to cefot

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 1,119.36 g/mol
• Formule: C₆₆H₇₀CaN₄O₁₀
• Degré de pureté: Min. 95%
• Couleur/Forme: White Powder